{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:15:14Z","timestamp":1779290114717,"version":"3.51.4"},"publisher-location":"Boston","reference-count":9,"publisher":"Kluwer Academic Publishers","isbn-type":[{"value":"0306477572","type":"print"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/0-306-48382-3_103","type":"book-chapter","created":{"date-parts":[[2006,2,18]],"date-time":"2006-02-18T15:57:40Z","timestamp":1140278260000},"page":"511-519","source":"Crossref","is-referenced-by-count":28,"title":["Interferon alfa-2a in the Treatment of Ocular Adamantiades-Beh\u00e7et\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Lothar","family":"Krause","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia R.","family":"Turnbull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Necip","family":"Torun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Pleyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos C.","family":"Zouboulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Foerster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"103_CR1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2165\/00003495-199142050-00006","volume":"42","author":"H. Yazici","year":"1991","unstructured":"Yazici, H., and Barnes, C.G., 1991, Practical treatment recommendations for pharmacotherapy of Beh\u00e7et\u2019s syndrome. Drugs 42: 796\u2013804.","journal-title":"Drugs"},{"key":"103_CR2","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1001\/archderm.134.8.1010","volume":"134","author":"Ch.C. Zouboulis","year":"1998","unstructured":"Zouboulis, Ch.C., and Orfanos, C.E., 1998, Treatment of Adamantiades-Beh\u00e7et disease with systemic interferon alfa. Arch. Dermatol. 134: 1010\u20131016.","journal-title":"Arch. Dermatol."},{"key":"103_CR3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1001\/archderm.138.4.467","volume":"138","author":"E. Alpsoy","year":"2002","unstructured":"Alpsoy, E., Durusoy, C., Yilmaz, E., et al., 2002, Interferon alfa-2a in the treatment of Beh\u00e7et disease: a randomized placebo-controlled and double-blind study. Arch. Dermatol. 138: 467\u2013471.","journal-title":"Arch. Dermatol."},{"key":"103_CR4","doi-asserted-by":"crossref","first-page":"0768","DOI":"10.1055\/s-2001-19687","volume":"218","author":"N. Stuebiger","year":"2001","unstructured":"Stuebiger, N., Koetter, I., Deuter, C., et al., 2001, M. Morbus Beh\u00e7et: Uveitis-Therapie mit Interferon a2a \u2014 prospektive klinische (Pilot-)Studie an 33 Patienten. Klin. Monatsbl. Augenheilkd. 218:0768\u2013773.","journal-title":"Klin. Monatsbl. Augenheilkd."},{"key":"103_CR5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1076\/ocii.8.4.293.6453","volume":"8","author":"B. Wechsler","year":"2000","unstructured":"Wechsler, B., Bodaghi, B., Huong, D.L., et al., 2000, Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Beh\u00e7et\u2019s disease. Ocul. Immunol. Inflamm. 8: 293\u2013301.","journal-title":"Ocul. Immunol. Inflamm."},{"key":"103_CR6","first-page":"371","volume":"41","author":"L. Krause","year":"2000","unstructured":"Krause, L., Adler, Y.D., Hoffmann, F., et al., 2000, Treatment of ocular Adamantiades-Beh\u00e7et\u2019s disease with interferon-alpha. Invest. Ophth. Vis. Sci. 41: 371.","journal-title":"Invest. Ophth. Vis. Sci."},{"key":"103_CR7","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/bjo.82.5.488","volume":"82","author":"I. K\u00f6tter","year":"1998","unstructured":"K\u00f6tter, I., Eckstein, A.K., St\u00dcbiger, N., et al., 1998, Treatment of ocular symptoms of Beh\u00e7et\u2019s disease with interferon-alpha-2a. Br. J. Ophthalmol. 82: 488\u2013494.","journal-title":"Br. J. Ophthalmol."},{"key":"103_CR8","first-page":"35","volume":"20","author":"O. Ozdemir","year":"1988","unstructured":"Ozdemir, O., Erkam, N., and Bakkaloglu, A., 1988, Results of pars plana vitrectomy in Beh\u00e7et\u2019s disease. Ann. Ophthalmol. 20: 35, 38.","journal-title":"Ann. Ophthalmol."},{"key":"103_CR9","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1034\/j.1600-0420.2001.079002192.x","volume":"79","author":"Y. Ozerturk","year":"2001","unstructured":"Ozerturk, Y., Bardak, Y., and Durmus, M., 2001, Vitreoretinal surgery in Beh\u00e7et\u2019s disease with severe ocular complications. Acta Ophthalmol. Scand. 79: 192\u2013196.","journal-title":"Acta Ophthalmol. Scand."}],"container-title":["Advances in Experimental Medicine and Biology","Adamantiades-Beh\u00e7et\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/0-306-48382-3_103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:30:29Z","timestamp":1619483429000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/0-306-48382-3_103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["0306477572"],"references-count":9,"URL":"https:\/\/doi.org\/10.1007\/0-306-48382-3_103","relation":{},"subject":[]}}